Catawba Capital Management’s Zimmer Biomet ZBH Stock Holding History

Catawba Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$4.67M	Sell	43,126 -118	-0.3%	-$12.8K	1.1%	31
2018 Q1	$4.58M	Sell	43,244 -139	-0.3%	-$16.1K	1.1%	29
2017 Q4	$5.08M	Sell	43,383 -1,460	-3%	-$165K	1.15%	28
2017 Q3	$5.1M	Sell	44,843 -10	-0%	-$1.15K	1.15%	25
2017 Q2	$5.59M	Sell	44,853 -358	-0.8%	-$42.4K	1.27%	22
2017 Q1	$5.36M	Buy	45,211 +5	+0%	+$567	1.17%	24
2016 Q4	$4.53M	Sell	45,206 -10	-0%	-$1.07K	1.06%	30
2016 Q3	$5.71M	Buy	45,216 +660	+1%	+$81.5K	1.35%	17
2016 Q2	$5.21M	Buy	44,556 +1,284	+3%	+$145K	1.26%	21
2016 Q1	$4.48M	Buy	43,272 +3,296	+8%	+$319K	1.14%	26
2015 Q4	$3.98M	Sell	39,976 -84	-0.2%	-$8.22K	1.08%	26
2015 Q3	$3.65M	Sell	40,060 -3,952	-9%	-$396K	1%	28
2015 Q2	$4.67M	Sell	44,012 -590	-1%	-$65.3K	1.11%	27
2015 Q1	$5.09M	Sell	44,602 -165	-0.4%	-$18.8K	1.17%	26
2014 Q4	$4.93M	Sell	44,767 -1,545	-3%	-$163K	1.14%	30
2014 Q3	$4.52M	Sell	46,312 -3,566	-7%	-$351K	1.05%	32
2014 Q2	$5.03M	Sell	49,878 -662	-1%	-$64.6K	1.13%	27
2014 Q1	$4.64M	Sell	50,540 -2,482	-5%	-$229K	1.11%	28
2013 Q4	$4.8M	Sell	53,022 -806	-1%	-$69.7K	1.15%	30
2013 Q3	$4.29M	Sell	53,828 -2,091	-4%	-$165K	1.12%	30
2013 Q2	$4.07M	Buy	+55,919	New	+$4.18M	1.13%	31

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Catawba Capital Management's ZBH Position: Q2 2018 in Review

Catawba Capital Management reduced its Zimmer Biomet (ZBH) stake by 0.27% in Q2 2018, selling an estimated $12.8K and leaving 43,126 shares worth $4.67M. The position accounts for 1.1% of the portfolio, ranked #31.

Catawba Capital Management first reported a position in ZBH in Q2 2013 and has held it in 21 quarters since. The position peaked at $5.71M in Q3 2016. 869 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

Catawba Capital Management held 43,126 shares of Zimmer Biomet worth $4.67M as of Q2 2018.
Catawba Capital Management sold 118 Zimmer Biomet shares in Q2 2018, an estimated $12.8K.
Zimmer Biomet made up 1.1% of Catawba Capital Management's portfolio in Q2 2018, its #31 holding.
Catawba Capital Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 21 quarters since.
Catawba Capital Management's Zimmer Biomet position peaked at $5.71M in Q3 2016.
869 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on Catawba Capital Management's 13F filing for Q2 2018, filed 11 Jul 2018.